- |||||||||| MT1002 / Shaanxi Micot Technology
Trial termination: MT1002 Phase II Study in ACS Patients With PCI (clinicaltrials.gov) - Oct 30, 2023
P2, N=6, Terminated,
Suspended --> Terminated; The study was decided to be terminated due to commercial considerations,?not the safety issues of the product?.
- |||||||||| MT1002 / Shaanxi Micot Technology
Enrollment change, Trial suspension, Trial primary completion date: MT1002 Phase II Study in ACS Patients With PCI (clinicaltrials.gov) - Jun 1, 2023
P2, N=6, Suspended,
Suspended --> Terminated; The study was decided to be terminated due to commercial considerations,?not the safety issues of the product?. N=20 --> 6 | Recruiting --> Suspended | Trial primary completion date: Mar 2023 --> Jul 2023
- |||||||||| MT1002 / Shaanxi Micot Technology
Enrollment change, Trial completion date, Trial termination, Trial primary completion date: Evaluate the Effects of Renal Impairment on the Pharmacokinetics and Pharmacodynamics (clinicaltrials.gov) - Jan 26, 2023
P1, N=2, Terminated,
N=20 --> 6 | Recruiting --> Suspended | Trial primary completion date: Mar 2023 --> Jul 2023 N=24 --> 2 | Trial completion date: Apr 2023 --> Jun 2022 | Recruiting --> Terminated | Trial primary completion date: Mar 2023 --> Jun 2022; Strategic decision
- |||||||||| MT1002 / Shaanxi Micot Technology
Trial completion date, Trial primary completion date: MT1002 Phase II Study in ACS Patients With PCI (clinicaltrials.gov) - Jan 25, 2023
P2, N=20, Recruiting,
N=24 --> 2 | Trial completion date: Apr 2023 --> Jun 2022 | Recruiting --> Terminated | Trial primary completion date: Mar 2023 --> Jun 2022; Strategic decision Trial completion date: Jan 2023 --> May 2023 | Trial primary completion date: Dec 2022 --> Mar 2023
- |||||||||| MT1002 / Shaanxi Micot Technology
Trial primary completion date: MT1002 Phase II Study in ACS Patients With PCI (clinicaltrials.gov) - Oct 25, 2022
P2, N=20, Recruiting,
Trial completion date: Jan 2023 --> May 2023 | Trial primary completion date: Dec 2022 --> Mar 2023 Trial primary completion date: Sep 2022 --> Dec 2022
- |||||||||| MT1002 / Shaanxi Micot Technology
Trial completion date, Trial primary completion date: MT1002 Phase II Study in ACS Patients With PCI (clinicaltrials.gov) - Apr 6, 2022
P2, N=20, Recruiting,
Trial completion date: Dec 2022 --> Apr 2023 | Trial primary completion date: Sep 2022 --> Mar 2023 Trial completion date: Jul 2022 --> Dec 2022 | Trial primary completion date: May 2022 --> Sep 2022
- |||||||||| MT1002 / Shaanxi Micot Technology
Enrollment open, Trial completion date, Trial primary completion date: MT1002 Phase II Study in ACS Patients With PCI (clinicaltrials.gov) - Nov 16, 2021
P2, N=20, Recruiting,
Trial completion date: Jul 2022 --> Dec 2022 | Trial primary completion date: May 2022 --> Sep 2022 Active, not recruiting --> Recruiting | Trial completion date: Oct 2021 --> Jul 2022 | Trial primary completion date: Aug 2021 --> May 2022
|
